Skip to main content

BAKER BROS. ADVISORS LP

Position in DNLI — Denali Therapeutics Inc.

CIK 1263508 NEW YORK, NY

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$96,047,121
+$24,398,577 QoQ
Shares Held
3,734,336
+0.1% QoQ
Ownership
2.34%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#12
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,393,772 across 78 Biotechnology names. DNLI ranks #25 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,047,121 3,734,336
2026-03-31 $71,648,544 3,731,695
2025-12-31 $61,610,284 3,731,695
2025-09-30 $54,184,211 3,731,695
2025-06-30 $52,206,413 3,731,695
2025-03-31 $50,732,393 3,731,695
2024-12-31 $76,051,944 3,731,695
2024-09-30 $108,704,275 3,731,695
2024-06-30 $86,649,957 3,731,695
2024-03-31 $76,574,381 3,731,695
2023-12-31 $55,950,426 2,607,196
2023-09-30 $47,284,021 2,292,003
2023-06-30 $42,946,552 1,455,322
2023-03-31 $25,084,523 1,088,738
2022-12-31 $30,277,803 1,088,738
2022-09-30 $18,068,369 588,738
2022-06-30 $17,326,559 588,738
2022-03-31 $2,854,701 88,738
2021-12-31 $3,957,714 88,738
2021-09-30 $4,476,832 88,738
2021-06-30 $6,960,608 88,738
2021-03-31 $5,066,939 88,738
2020-12-31 $7,432,694 88,738
2020-09-30 $3,561,502 99,400
2020-06-30 $2,536,482 104,900
2020-03-31 $1,836,799 104,900